Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $22.75 $29.27 Wednesday, 8th May 2024 FDMT stock ended at $26.33. This is 1.75% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.40% from a day low at $25.90 to a day high of $26.78.
90 days $22.75 $36.25
52 weeks $9.44 $36.25

Historical 4D Molecular Therapeutics, Inc. prices

Date Open High Low Close Volume
May 08, 2024 $26.26 $26.78 $25.90 $26.33 284 650
May 07, 2024 $26.79 $27.09 $26.26 $26.80 332 976
May 06, 2024 $26.47 $26.99 $26.47 $26.76 365 497
May 03, 2024 $27.21 $27.84 $26.20 $26.38 315 075
May 02, 2024 $25.31 $26.54 $24.93 $26.38 400 436
May 01, 2024 $24.00 $26.59 $24.00 $25.39 649 701
Apr 30, 2024 $23.76 $24.56 $23.57 $23.93 346 546
Apr 29, 2024 $23.58 $24.66 $23.47 $24.25 315 392
Apr 26, 2024 $23.45 $23.86 $22.75 $23.25 317 415
Apr 25, 2024 $23.51 $23.98 $22.91 $23.53 440 455
Apr 24, 2024 $25.19 $25.38 $24.23 $24.25 290 372
Apr 23, 2024 $26.45 $26.84 $24.69 $24.81 565 453
Apr 22, 2024 $25.60 $26.92 $24.57 $26.39 471 429
Apr 19, 2024 $24.61 $25.56 $24.38 $25.25 615 155
Apr 18, 2024 $25.04 $25.27 $24.71 $24.78 406 055
Apr 17, 2024 $26.94 $26.99 $25.15 $25.30 500 700
Apr 16, 2024 $25.74 $27.24 $25.74 $26.75 472 249
Apr 15, 2024 $27.89 $27.97 $25.94 $26.25 597 229
Apr 12, 2024 $27.53 $27.72 $26.09 $26.35 389 457
Apr 11, 2024 $27.19 $27.86 $26.68 $27.70 627 186
Apr 10, 2024 $26.50 $27.29 $25.68 $26.93 509 737
Apr 09, 2024 $28.79 $29.21 $26.80 $27.10 543 560
Apr 08, 2024 $28.65 $29.27 $28.23 $28.75 497 828
Apr 05, 2024 $27.40 $28.71 $26.90 $28.60 367 188
Apr 04, 2024 $28.17 $28.86 $27.42 $27.64 443 914
Click to get the best stock tips daily for free!

About 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics. 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; ... FDMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT